» Articles » PMID: 16648775

The Double-blind Sham-controlled Study of High-frequency RTMS (20 Hz) for Negative Symptoms in Schizophrenia: Negative Results

Overview
Specialties Endocrinology
Neurology
Date 2006 May 2
PMID 16648775
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the prefrontal cortex is a promising method for the treatment of negative symptoms of schizophrenia. Using double-blind sham-controlled parallel design, we evaluated the effect of HF-rTMS over the left dorsolateral prefrontal cortex (DLPFC) on negative symptoms in patients with schizophrenia. Sixteen schizophrenia patients with predominantly negative symptoms on stable antipsychotic medication were treated with 20 Hz rTMS (90% of motor threshold, 2000 stimuli per session) over ten days within 2 weeks with six weeks follow-up. The effect was assessed using PANSS, CGI, MADRS and neuropsychological tests. We failed to find any significant effect of active rTMS. Sham rTMS showed a trend for improvement over time on positive and negative subscales of PANSS and MADRS. Between-group comparisons failed to reveal any significant differences on any rating scales except a positive subscale of PANSS after 8 weeks. Results from our study did not confirm that HF-rTMS over the left DLPCF affects the negative symptoms of schizophrenia and alternative rTMS approaches are discussed.

Citing Articles

Effects of non-invasive brain stimulation on impulsivity in patients with mental disorders: a systematic review and meta-analysis of randomised clinical trials.

Machado Y, Oliveira M, Mundoca M, Viana B, de Miranda D, Romano-Silva M Gen Psychiatr. 2024; 37(6):e101220.

PMID: 39737338 PMC: 11683908. DOI: 10.1136/gpsych-2023-101220.


The efficacy and safety of dual-target rTMS over dorsolateral prefrontal cortex (DLPFC) and cerebellum in the treatment of negative symptoms in first-episode schizophrenia: Protocol for a multicenter, randomized, double-blind, sham-controlled study.

Wang J, Wei Y, Hu Q, Tang Y, Zhu H, Wang J Schizophr Res Cogn. 2024; 39:100339.

PMID: 39687049 PMC: 11646743. DOI: 10.1016/j.scog.2024.100339.


Early efficacy of rTMS intervention at week 2 predicts subsequent responses at week 24 in schizophrenia in a randomized controlled trial.

Ye S, Guan X, Xiu M, Wu F, Huang Y Neurotherapeutics. 2024; 21(5):e00392.

PMID: 38944636 PMC: 11579878. DOI: 10.1016/j.neurot.2024.e00392.


10 Hz repetitive transcranial magnetic stimulation (rTMS) may improve cognitive function: An exploratory study of schizophrenia patients with auditory hallucinations.

Mao J, Fan K, Zhang Y, Wen N, Fang X, Ye X Heliyon. 2023; 9(9):e19912.

PMID: 37809845 PMC: 10559318. DOI: 10.1016/j.heliyon.2023.e19912.


Delayed improvements in visual memory task performance among chronic schizophrenia patients after high-frequency repetitive transcranial magnetic stimulation.

Du X, Li Z, Yuan N, Yin M, Zhao X, Lv X World J Psychiatry. 2022; 12(9):1169-1182.

PMID: 36186505 PMC: 9521529. DOI: 10.5498/wjp.v12.i9.1169.